Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Restless legs syndrome | D012148 | EFO_0004270 | G25.81 | — | — | 1 | — | — | 1 |
Psychomotor agitation | D011595 | — | — | — | — | 1 | — | — | 1 |
Syndrome | D013577 | — | — | — | — | 1 | — | — | 1 |
Drug common name | Nimotuzumab |
INN | nimotuzumab |
Description | Nimotuzumab (humanized mab) |
Classification | Antibody |
Drug class | monoclonal antibodies |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | >3GKW:H|Heavy chain of the antibody Nimotuzumab
QVQLQQSGAEVKKPGSSVKVSCKASGYTFTNYYIYWVRQAPGQGLEWIGGINPTSGGSNFNEKFKTRVTITADESSTTAY
MELSSLRSEDTAFYFCTRQGLWFDSDGRGFDFWGQGTTVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPV
TVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVP
>3GKW:L|Light chain of the antibody Nimotuzumab
DIQMTQSPSSLSASVGDRVTITCRSSQNIVHSNGNTYLDWYQQTPGKAPKLLIYKVSNRFSGVPSRFSGSGSGTDFTFTI
SSLQPEDIATYYCFQYSHVPWTFGQGTKLQITREVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQ
SGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC |
PDB | 3GKW |
CAS-ID | — |
RxCUI | — |
ChEMBL ID | CHEMBL2108359 |
ChEBI ID | — |
PubChem CID | — |
DrugBank | — |
UNII ID | 6NS400BXKH (ChemIDplus, GSRS) |